Morphologic Alteration of Metastatic Neuroblastic Tumor in Bone Marrow after Chemotherapy
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: The aim of this study is to evaluate the histologic features of metastatic neuroblastic tumors (NTs) in bone marrow (BM) before and after chemotherapy in comparison with those of primary NTs. Methods: A total of 294 biopsies from 48 children diagnosed with NTs with BM metastasis were examined. There were 48 primary neoplasm biopsies, 48 BM biopsies before chemotherapy, 36 primary neoplasm excisional biopsies after chemotherapy, and 162 BM biopsies after chemotherapy. Results: Metastatic NTs in BM before chemotherapy were composed of undifferentiated and/or differentiating neuroblasts, but had neither ganglion cells nor Schwannian stroma. Metastatic foci of BM after chemotherapy were found to have differentiated into ganglion cells or Schwannian stroma, which became more prominent after further cycles of chemotherapy. Persistence of NTs or tumor cell types in BM after treatment did not show statistically significant correlation to patients’ outcome. However, three out of five patients who newly developed poorly differentiated neuroblasts in BM after treatment expired due to disease progression. Conclusions: Metastatic NTs in BM initially consist of undifferentiated or differentiating neuroblasts regardless of the primary tumor subtype, and become differentiated after chemotherapy. Newly appearing poorly differentiated neuroblasts after treatment might be an indicator for poor prognosis.
Abstract
Background: The aim of this study is to evaluate the histologic features of metastatic neuroblastic tumors (NTs) in bone marrow (BM) before and after chemotherapy in comparison with those of primary NTs. Methods: A total of 294 biopsies from 48 children diagnosed with NTs with BM metastasis were examined. There were 48 primary neoplasm biopsies, 48 BM biopsies before chemotherapy, 36 primary neoplasm excisional biopsies after chemotherapy, and 162 BM biopsies after chemotherapy. Results: Metastatic NTs in BM before chemotherapy were composed of undifferentiated and/or differentiating neuroblasts, but had neither ganglion cells nor Schwannian stroma. Metastatic foci of BM after chemotherapy were found to have differentiated into ganglion cells or Schwannian stroma, which became more prominent after further cycles of chemotherapy. Persistence of NTs or tumor cell types in BM after treatment did not show statistically significant correlation to patients’ outcome. However, three out of five patients who newly developed poorly differentiated neuroblasts in BM after treatment expired due to disease progression. Conclusions: Metastatic NTs in BM initially consist of undifferentiated or differentiating neuroblasts regardless of the primary tumor subtype, and become differentiated after chemotherapy. Newly appearing poorly differentiated neuroblasts after treatment might be an indicator for poor prognosis.
참고문헌 (28)
- Esiashvili N, "Neuroblastoma in adults: incidence and survival analysis based on SEER data", Pediatr Blood Cancer, 49, pp.41~46 (2007)
- Bernstein ML, "A population-based study of neuroblastoma incidence, survival, and mortality in North America", J Clin Oncol, 10, pp.323~329 (1992)
- Moon SB, "Neuroblastoma: treatment outcome after incomplete resection of primary tumors", Pediatr Surg Int, 25, pp.789~793 (2009)
- 정근영, "Primary Hepatic Neuroblastoma - A Case Report -", Journal of Pathology and Translational Medicine, 45(4), pp.423~427 (2011), 대한병리학회
- Moss TJ, "Prognostic value of immunocytologic detection of bone marrow metastases in neuroblastoma", N Engl J Med, 324, pp.219~226 (1991)
- Shimada H, "Pathology of peripheral neuroblastic tumors, In Neuroblastoma", pp.87~95 (2005), Springer
- Shimada H, "The International Neuroblastoma Pathology Classification (the Shimada system)", Cancer, 86, pp.364~372 (1999)
- Peuchmaur M, "Revision of the International Neuroblastoma Pathology classification: confirmation of favorable and unfavorable prognostic subsets in ganglioneuroblastoma, nodular", Cancer, 98, pp.2274~2281 (2003)
- Shono K, "Clinical implications of minimal disease in the bone marrow and peripheral blood in neuroblastoma", J Pediatr Surg, 35, pp.1415~1420 (2000)
- 안수민, "Clinicopathological Analysis of 21 Thymic Neuroendocrine Tumors", Journal of Pathology and Translational Medicine, 46(3), pp.221~225 (2012), 대한병리학회
- 하승연, "Morphologic Analysis of Pulmonary Neuroendocrine Tumors", Journal of Pathology and Translational Medicine, 47(1), pp.16~20 (2013), 대한병리학회
- Shimada H, "Terminology and morphologic criteria of neuroblastic tumors: recommendations by the International Neuroblastoma Pathology Committee", Cancer, 86, pp.349~363 (1999)
- Miura K, "Olfactory neuroblastoma with epithelial and endocrine differentiation transformed into ganglioneuroma after chemoradiotherapy", Pathol Int, 51, pp.942~947 (2001)
- Ogita S, "Neuroblastoma: incomplete differentiation on the way to maturation or morphological alteration resembling maturity?", Oncology, 45, pp.148~152 (1988)
- Kane SV, "Chemotherapy-induced neuronal maturation in sinonasal teratocarcinosarcoma: a unique observation", Head Neck Pathol, 3, pp.31~36 (2009)
- Raaf JH, "Induction of neuroblastoma maturation by a new chemotherapy protocol", Med Pediatr Oncol, 10, pp.275~282 (1982)
- Goldstein MN, "Drug-induced differentiation of human neuroblastoma: transformation into ganglion cells with mitomycin-C", Results Probl Cell Differ, 11, pp.259~264 (1980)
- Reynolds CP, "Retinoid therapy of high-risk neuroblastoma", Cancer Lett, 197, pp.185~192 (2003)
- Ambros IM, "Role of ploidy, chromosome 1p, and Schwann cells in the maturation of neuroblastoma", N Engl J Med, 334, pp.1505~1511 (1996)
- Reynolds ML, "Reciprocal Schwann cell-axon interactions", Curr Opin Neurobiol, 3, pp.683~693 (1993)
- Cohn SL, "The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report", J Clin Oncol, 27, pp.289~297 (2009)
- George RE, "Tumor histology during induction therapy in patients with high-risk neuroblastoma", Pediatr Blood Cancer, 59, pp.506~510 (2012)
- Chatten J, "Prognostic value of histopathology in advanced neuroblastoma: a report from the Childrens Cancer Study Group", Hum Pathol, 19, pp.1187~1198 (1988)
- Burgues O, "Prognostic value of the International Neuroblastoma Pathology Classification in Neuroblastoma (Schwannian stroma-poor) and comparison with other prognostic factors: a study of 182 cases from the Spanish Neuroblastoma Registry", Virchows Arch, 449, pp.410~420 (2006)
- Spix C, "Neuroblastoma incidence and survival in European children (1978-1997): report from the Automated Childhood Cancer Information System project", Eur J Cancer, 42, pp.2081~2091 (2006)
- Morandi F, "Bone marrow-infiltrating human neuroblastoma cells express high levels of calprotectin and HLA-G proteins", PLoS One, 7, pp.e29922~ (2012)
- 박상혁, "Presence of Differentiating Neuroblasts in Bone Marrow is a Favorable Prognostic Factor for Bone Marrow Metastatic Neuroblastoma at Diagnosis", Annals of Laboratory Medicine, 33(2), pp.89~96 (2013), 대한진단검사의학회
- metaiodobenzylguanidine in chemoresistant neuroblastoma, "Med Pediatr Oncol", 1999, 418~419